metoprolol succinate · Spil · NDA 210428
Kapspargo Sprinkle
Earliest generic entry, as listed · earliest of 4 marketed strengths
9 Jul 2035
Blocked by patent: US 9504655, US 9700530.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9504655 | drug product · sets the listed date | 9 Jul 2035 |
| US 9700530 | drug product · sets the listed date | 9 Jul 2035 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 210428 · 001 · RLD | capsule, extended release, oral | EQ 25MG TARTRATE | 9 Jul 2035 |
| 210428 · 002 · RLD | capsule, extended release, oral | EQ 50MG TARTRATE | 9 Jul 2035 |
| 210428 · 003 · RLD | capsule, extended release, oral | EQ 100MG TARTRATE | 9 Jul 2035 |
| 210428 · 004 · RLD | capsule, extended release, oral | EQ 200MG TARTRATE | 9 Jul 2035 |